文献速递神经肿瘤

细胞外谷氨酸和IDH1R132H抑制剂通过提升氧化还原电位促进胶质瘤生长

Extracellular glutamate and IDH1R132H inhibitor promote glioma growth by boosting redox potential.
PubMed 文献 · J Neurooncol · 2020-02-04

本研究比较二维与三维培养下IDH1R132H杂合与半合子胶质瘤细胞的基因表达和移植瘤生长,发现三维培养更贴近IDH1R132H胶质瘤生物学;细胞外谷氨酸和AGI-5198均提升氧化还原电位促进三维生长,谷氨酸作用依赖GLUD2,作者提示IDH1R132H抑制剂在治疗中可能产生适得其反的后果。

要点

  • 三维培养比二维培养更贴近IDH1R132H胶质瘤生物学。
  • 细胞外谷氨酸和AGI-5198均提升氧化还原电位以促进IDH1R132H杂合子细胞三维生长。
  • 谷氨酸的刺激作用依赖GLUD2表达,AGI-5198的刺激作用不依赖GLUD2。

核心结论

  • 三维培养与IDH1R132H胶质瘤生物学更相关。
  • IDH1R132H胶质瘤中氧化还原稳态的重要性提示可探索代谢通路作为治疗靶点,而IDH1R132H抑制剂在患者治疗中可能产生适得其反的后果。

研究设计与样本

  • 对二维和三维条件下培养的IDH1R132H杂合子和IDH1R132H半合子胶质瘤细胞RNA测序数据进行无监督层次聚类和基因集富集分析。
  • 在皮下和颅内移植中比较IDH1R132H杂合子和IDH1R132H半合子肿瘤生长。
  • 采用针对谷氨酸脱氢酶2基因(GLUD2)表达的短发夹RNA确定谷氨酸和突变IDH1抑制剂AGI-5198对IDH1R132H杂合子细胞氧化还原电位的影响。

主要发现

  • 与IDH1R132H杂合子细胞相反,三维培养而非二维培养的IDH1R132H半合子细胞与更恶性的胶质瘤聚类,具有胶质母细胞瘤间质特征,并表现出侵袭性肿瘤生长。
  • 细胞外谷氨酸和AGI-5198均刺激氧化还原电位以促进IDH1R132H杂合子细胞三维生长,但GLUD2表达是谷氨酸刺激所必需,而非AGI-5198刺激所必需。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Somatic mutations of the isocitrate dehydrogenase 1 (IDH1) gene, mostly substituting Arg132 with histidine, are associated with better patient survival, but glioma recurrence and progression are nearly inevitable, resulting in disproportionate morbidity and mortality. Our previous studies demonstrated that in contrast to hemizygous IDH1R132H (loss of wild-type allele), heterozygous IDH1R132H is intrinsically glioma suppressive but its suppression of three-dimensional (3D) growth is negated by extracellular glutamate and reducing equivalent. This study sought to understand the importance of 3D culture in IDH1R132H biology and the underlying mechanism of the glutamate effect. METHODS: RNA sequencing data of IDH1R132H-heterozygous and IDH1R132H-hemizygous glioma cells cultured under two-dimensional (2D) and 3D conditions were subjected to unsupervised hierarchal clustering and gene set enrichment analysis. IDH1R132H-heterozygous and IDH1R132H-hemizygous tumor growth were compared in subcutaneous and intracranial transplantations. Short-hairpin RNA against glutamate dehydrogenase 2 gene (GLUD2) expression was employed to determine the effects of glutamate and the mutant IDH1 inhibitor AGI-5198 on redox potential in IDH1R132H-heterozygous cells. RESULTS: In contrast to IDH1R132H-heterozygous cells, 3D-cultured but not 2D-cultured IDH1R132H-hemizygous cells were clustered with more malignant gliomas, possessed the glioblastoma mesenchymal signature, and exhibited aggressive tumor growth. Although both extracellular glutamate and AGI-5198 stimulated redox potential for 3D growth of IDH1R132H-heterozygous cells, GLUD2 expression was required for glutamate, but not AGI-5198, stimulation. CONCLUSION: 3D culture is more relevant to IDH1R132H glioma biology. The importance of redox homeostasis in IDH1R132H glioma suggests that metabolic pathway(s) can be explored for therapeutic targeting, whereas IDH1R132H inhibitors may have counterproductive consequences in patient treatment.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Tiburcio PDB, Gillespie DL, Jensen RL, et al. Extracellular glutamate and IDH1R132H inhibitor promote glioma growth by boosting redox potential. J Neurooncol. 2020. PMID: 32020473. doi:10.1007/s11060-019-03359-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。